Nonalcoholic Fatty Liver Disease Liver Fat Score and Fat Equation to Predict and Quantitate Hepatic Steatosis: Promising But Not Prime Time!
No abstract is available. To read the body of this article, please view the Full Text online.
Conflicts of interest The author discloses the following: Dr Chalasani served within the past 12 months as a paid consultant to KariBio, Metabasis, Atherogenics, Advanced Life Sciences, Johnson and Johnson, Debiovision, Eli Lilly, and Amylin. Within the past 12 months, he has participated in clinical studies with Gilead and Monarch LifeSciences.
Funding Supported in part by K24 DK 069290.
PII: S0016-5085(09)01188-3
doi:10.1053/j.gastro.2009.07.032
© 2009 AGA Institute. Published by Elsevier Inc. All rights reserved.
Refers to article:
-

Prediction of Non-Alcoholic Fatty Liver Disease and Liver Fat Using Metabolic and Genetic Factors
, 15 June 2009


